Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 18.64
+0.47 (2.59%)
Jan 23, 2026, 3:00 PM CST
SHA:688488 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -87.1 | -141.2 | -76.07 | -124.09 | -29.99 | 39.77 | Upgrade |
Depreciation & Amortization | 52.73 | 52.73 | 45.1 | 37.85 | 30.21 | 21.63 | Upgrade |
Other Amortization | 3.97 | 3.97 | 2.65 | 3.51 | 2.44 | 1.81 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -0.07 | -0.03 | -1.58 | - | Upgrade |
Asset Writedown & Restructuring Costs | 65.63 | 65.63 | 23.8 | 0.31 | - | 0.1 | Upgrade |
Loss (Gain) From Sale of Investments | -17.73 | -17.73 | -14.16 | -14.14 | -8.09 | -3.04 | Upgrade |
Provision & Write-off of Bad Debts | -3.34 | -3.34 | 3.72 | 8.87 | -2.49 | -1.65 | Upgrade |
Other Operating Activities | -7.2 | 18.48 | 11.77 | 36.21 | 10.89 | 4.03 | Upgrade |
Change in Accounts Receivable | 76.98 | 76.98 | -82.92 | -66.66 | 31.35 | 34.07 | Upgrade |
Change in Inventory | -44.28 | -44.28 | -52.4 | -74.62 | -36.7 | -23.36 | Upgrade |
Change in Accounts Payable | -14.34 | -14.34 | -8.84 | 118.87 | 3.87 | -17.3 | Upgrade |
Change in Other Net Operating Assets | -5.31 | -5.31 | -2.8 | - | - | - | Upgrade |
Operating Cash Flow | -9.08 | -37.5 | -166.22 | -92.55 | -12.37 | 56.17 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | - | -0.05% | Upgrade |
Capital Expenditures | -14.81 | -44.56 | -71.2 | -140.3 | -94.78 | -42.43 | Upgrade |
Sale of Property, Plant & Equipment | 0.24 | 0.12 | 1.32 | 0.68 | 0.01 | 0 | Upgrade |
Investment in Securities | 123.6 | 125.35 | 135.88 | -274.75 | 311.12 | -535 | Upgrade |
Other Investing Activities | -65.26 | 4.19 | 7.44 | 8.64 | 14.17 | 2.98 | Upgrade |
Investing Cash Flow | 38.72 | 85.1 | 73.44 | -405.72 | 230.53 | -574.45 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 60 | Upgrade |
Long-Term Debt Issued | - | 410.87 | 395.29 | 205 | - | - | Upgrade |
Total Debt Issued | 433.82 | 410.87 | 395.29 | 205 | - | 60 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -192 | Upgrade |
Long-Term Debt Repaid | - | -340.15 | -198.33 | -5.5 | -2.76 | - | Upgrade |
Total Debt Repaid | -433.41 | -340.15 | -198.33 | -5.5 | -2.76 | -192 | Upgrade |
Net Debt Issued (Repaid) | 0.42 | 70.72 | 196.96 | 199.5 | -2.76 | -132 | Upgrade |
Issuance of Common Stock | - | - | 5.48 | - | - | 777.64 | Upgrade |
Common Dividends Paid | -21.42 | -15.85 | -11.66 | -3.47 | -20.16 | -3.12 | Upgrade |
Other Financing Activities | 0.46 | - | - | - | - | -15.82 | Upgrade |
Financing Cash Flow | -20.55 | 54.86 | 190.78 | 196.03 | -22.92 | 626.7 | Upgrade |
Foreign Exchange Rate Adjustments | 0.02 | -0.01 | 0 | 0.47 | -0.15 | -0.16 | Upgrade |
Net Cash Flow | 9.11 | 102.46 | 98 | -301.77 | 195.08 | 108.27 | Upgrade |
Free Cash Flow | -23.89 | -82.06 | -237.43 | -232.85 | -107.15 | 13.74 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | -39.47% | Upgrade |
Free Cash Flow Margin | -3.56% | -19.64% | -57.72% | -95.34% | -41.90% | 4.75% | Upgrade |
Free Cash Flow Per Share | -0.07 | -0.20 | -0.56 | -0.56 | -0.25 | 0.04 | Upgrade |
Cash Income Tax Paid | 89.19 | 22.87 | 22.29 | -6.67 | 11.66 | 22.74 | Upgrade |
Levered Free Cash Flow | -28.56 | -9.98 | -247.7 | -196.07 | -81.12 | 9.04 | Upgrade |
Unlevered Free Cash Flow | -18.47 | -0.38 | -240.35 | -193.62 | -80.97 | 10.87 | Upgrade |
Change in Working Capital | -16.04 | -16.04 | -162.97 | -41.05 | -13.77 | -6.48 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.